Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Editorial: NLRP3 Inflammasome:...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Editorial: NLRP3 Inflammasome: Regulatory Mechanisms, Role in Health and Disease and Therapeutic Potential

Editorial: NLRP3 Inflammasome: Regulatory Mechanisms, Role in Health and Disease and Therapeutic Potential

Bibliographic Details
Main Authors: Oleg V. Chernikov, Jong-Seok Moon, Ann Chen, Kuo-Feng Hua
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Immunology
Subjects:
NLRP3 inflammasome
inflammatory disease
therapeutic approach
drug target
inflammation
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.765199/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.765199/full

Similar Items

  • Research advances in the regulatory mechanisms of NLRP3 inflammasome activation
    by: Liu Feng, et al.
    Published: (2024-06-01)
  • NLRP3 Inflammasome as a Therapeutic Target for Atherosclerosis: A Focus on Potassium Outflow
    by: Yi-Jing Jin, et al.
    Published: (2022-07-01)
  • A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases
    by: Callum AH Docherty, et al.
    Published: (2023-01-01)
  • NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword
    by: Shaima'a Hamarsheh, et al.
    Published: (2020-07-01)
  • Future Therapeutics: Targeting the NLRP3 Inflammasome Pathway to Manage Diabetic Retinopathy Development and Progression
    by: Charisse Y. J. Kuo, et al.
    Published: (2024-06-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs